Boryczka S, Wietrzyk J, Opolski A
Department of Organic Chemistry, Silesian School of Medicine, Sosnowiec, Poland.
Pharmazie. 2002 Mar;57(3):151-4.
The series of new 3,4-disubstituted thioquinolines which possess one or two O, S, Se-propargyl groups has been synthesized on the basis of the reaction of thioquinanthrene with alkoxides. All the compounds obtained were tested for their antiproliferative activity in vitro against the cells of three human cancer cell lines: SW707 (colon cancer), T47D (breast cancer), and HCV29T (bladder cancer). Two compounds, 4-(3-hydroxypropoxy)-3'-propargylthio-3,4'-diquinolinyl sulfide (3) and 3-methylthio-4-propargylselenoquinoline (13) exhibited significant cytostatic activity (ID50 < 4 micrograms/ml) against the cells of all the human cancer lines used and are good candidates for further anticancer activity studies in vitro using a broad panel of human and murine cell lines and for in vivo preclinical screening in different mouse transplantable tumor models.
基于硫代喹蒽与醇盐的反应,合成了一系列含有一个或两个O、S、Se-炔丙基的新型3,4-二取代硫代喹啉。对所得到的所有化合物进行了体外抗增殖活性测试,以检测其对三种人类癌细胞系(SW707(结肠癌)、T47D(乳腺癌)和HCV29T(膀胱癌))细胞的活性。两种化合物,4-(3-羟基丙氧基)-3'-炔丙基硫代-3,4'-二喹啉基硫醚(3)和3-甲硫基-4-炔丙基硒代喹啉(13),对所有所使用的人类癌细胞系均表现出显著的细胞生长抑制活性(ID50 < 4微克/毫升),是使用广泛的人类和小鼠细胞系进行进一步体外抗癌活性研究以及在不同小鼠可移植肿瘤模型中进行体内临床前筛选的良好候选物。